Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Selective induction of mitophagy (PINK1-Parkin)

Selective Mitophagy & PINK1-Parkin Cascade · Cellular bioenergetics and mitochondrial dynamics

Selectively tags damaged, depolarized or aging mitochondria and activates the PINK1-Parkin ubiquitination or BNIP3L pathway. This guides autophagolysosomes to engulf and digest them and drives the renewal and regeneration of healthy mitochondria.

Why it matters: A core quality-control target in aging and metabolic syndrome, where dysfunctional mitochondria pile up, release large amounts of reactive oxygen species and trigger the NLRP3 inflammasome. Promoting new mitochondria without clearing diseased ones tends to worsen oxidative damage to cells.

Molecular targets: PINK1, Parkin E3 ligase, BNIP3L/NIX, LC3-II binding receptor, Lysosomal acid hydrolases

Supplements acting on this mechanism (ranked by strength and evidence)

Urolithin A

★★★★☆Mechanism evidence: grade A

Urolithin A can modulate markers of the PINK1/Parkin pathway in muscle. In one human randomized trial, phosphorylated Parkin rose in muscle biopsies from the 500 mg/day group, and the analysis was mainly a within-group before-and-after comparison. Autophagic flux and clinical effects remain undetermined.

Spermidine

★★☆☆☆Mechanism evidence: grade C

Mitophagy increased in the hearts of mice given oral spermidine, which shows this effect can occur in living animals. Direct evidence for the PINK1/Parkin pathway comes mainly from cell experiments and has not been confirmed in humans.

Open in the interactive app ›